Pharmacist-led intervention on chronic pain management: A systematic review and meta-analysis

Parbati Thapa, Shaun Wen Huey Lee, Bhuvan Kc, Juman Abdulelah Dujaili, Mohamed Izham Mohamed Ibrahim, Sudesh Gyawali, Parbati Thapa, Shaun Wen Huey Lee, Bhuvan Kc, Juman Abdulelah Dujaili, Mohamed Izham Mohamed Ibrahim, Sudesh Gyawali

Abstract

Aims: Pharmacists have been contributing to the management of chronic pain, ensuring the quality use of medicine. However, there is diversity in the interventions provided by pharmacists and their impact.

Methods: Six electronic databases were searched from inception until June 2020 for articles published in English examining the intervention provided by the pharmacist in chronic pain management. Studies investigating the impact of pharmacist intervention individually or multidisciplinary teams including pharmacists for chronic pain management were included.

Results: Fourteen studies (2365 participants) were included in the current review. Six studies were randomized controlled trials while the remainder were observational studies in which pharmacists provided intervention individually or in collaboration with other healthcare professionals. Medication review was the most common intervention provided by the pharmacist. The pooled analysis found that pharmacist-led interventions reduced the pain intensity (-0.22; 95% confidence interval [CI]: -0.35 to -0.09; moderate certainty) among participants with chronic pain. Opiate stewardship provided by pharmacists was effective; however, mixed results were noted on the impact of the intervention on physical functioning, anxiety, depression and quality of life. Pharmacist intervention was more expensive than treatment as usual.

Conclusions: Pharmacists contribute substantially to chronic pain management, ensuring the quality use of medicine, resulting in reduced pain intensity. Further studies with rigorous design are needed to measure the impact of pharmacist-provided intervention individually or in a multidisciplinary team on the economic benefit and other health outcomes.

Keywords: chronic pain; medication review; pain intensity; pain management; pharmacist; systematic review.

© 2021 British Pharmacological Society.

References

REFERENCES

    1. Treede RD, Rief W, Barke A, et al. Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11). Pain. 2019;160(1):19-27.
    1. Mills SEE, Nicolson KP, Smith BH. Chronic pain: a review of its epidemiology and associated factors in population-based studies. Br J Anaesth. 2019;123(2):e273-e283.
    1. Sá KN, Moreira L, Baptista AF, et al. Prevalence of chronic pain in developing countries: systematic review and meta-analysis. PAIN Reports. 2019;4(6):e779.
    1. Gaskin DJ, Richard P. The economic costs of pain in the United States. J Pain. 2012;13(8):715-724.
    1. Woo AK. Depression and anxiety in pain. Reviews in Pain. 2010;4(1):8-12.
    1. Yang J, Bauer BA, Wahner-Roedler DL, Chon TY, Xiao L. The modified WHO analgesic ladder: is it appropriate for chronic non-cancer pain? J Pain Res. 2020;13:411-417.
    1. Roe M, Sehgal A. Pharmacology in the management of chronic pain. Anaesth Intensive Care Med. 2016;17(11):548-551.
    1. Giannitrapani KF, Glassman PA, Vang D, et al. Expanding the role of clinical pharmacists on interdisciplinary primary care teams for chronic pain and opioid management. BMC Fam Pract. 2018;19(1):107.
    1. Bennett MI, Bagnall AM, Raine G, et al. Educational interventions by pharmacists to patients with chronic pain: systematic review and meta-analysis. Clin J Pain. 2011;27(7):623-630.
    1. Hadi AM, Alldred DP, Briggs M, Munyombwe T, Closs SJ. Effectiveness of pharmacist-led medication review in chronic pain management: systematic review and meta-analysis. Clin J Pain. 2014;30(11):1006-1014.
    1. Mishriky J, Stupans I, Chan V. Expanding the role of Australian pharmacists in community pharmacies in chronic pain management-a narrative review. Pharm Pract (Granada). 2019;17(1):1410.
    1. Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.
    1. Sterne JA, Hernán MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.
    1. Cochrane, Review Manager (RevMan) [Computer program]. Version 5.4. Copenhagen: The Nordic Cochrane Centre; 2020.
    1. Hoffmann W, Herzog B, Mühlig S, et al. Pharmaceutical care for migraine and headache patients: a community-based, randomized intervention. Ann Pharmacother. 2008;42(12):1804-1813.
    1. Marra CA, Cibere J, Grubisic M, et al. Pharmacist-initiated intervention trial in osteoarthritis: a multidisciplinary intervention for knee osteoarthritis. Arthritis Care Res. 2012;64(12):1837-1845.
    1. Hay EM, Foster NE, Thomas E, et al. Effectiveness of community physiotherapy and enhanced pharmacy review for knee pain in people aged over 55 presenting to primary care: pragmatic randomised trial. BMJ. 2006;333(7576):995.
    1. Bruhn H, Bond CM, Elliott AM, et al. Pharmacist-led management of chronic pain in primary care: results from a randomised controlled exploratory trial. BMJ Open. 2013;3(4):e002361.
    1. Neilson AR, Bruhn H, Bond CM, et al. Pharmacist-led management of chronic pain in primary care: costs and benefits in a pilot randomised controlled trial. BMJ Open. 2015;5(4):e006874.
    1. Gammaitoni AR, Gallagher RM, Welz M, Gracely EJ, Knowlton CH, Voltis-Thomas O. Palliative pharmaceutical care: a randomized, prospective study of telephone-based prescription and medication and counseling services for treating chronic pain. Pain Med. 2000;1(4):317-331.
    1. Boren LL, Locke AM, Friedman AS, Blackmore CC, Woolf R. Team-based medicine: incorporating a clinical pharmacist into pain and opioid practice management. PM&R. 2019;11(11):1170-1177.
    1. Semerjian M, Durham MJ, Mirzaian E, Lou M, Richeimer SH. Clinical pharmacy services in a multidisciplinary specialty pain clinic. Pain Pract. 2019;19(3):303-309.
    1. White LD, Summers P, Scott A. Changes in clinical status after completion of an interdisciplinary pain management programme incorporating pain neurophysiology education. Physiother Can. 2018;70(4):382-392.
    1. Chelminski PR, Ives TJ, Felix KM, et al. A primary care, multi-disciplinary disease management program for opioid-treated patients with chronic non-cancer pain and a high burden of psychiatric comorbidity. BMC Health Serv Res. 2005;5:1-3.
    1. Takahashi N, Takatsuki K, Kasahara S, Yabuki S. Multidisciplinary pain management program for patients with chronic musculoskeletal pain in Japan: a cohort study. J Pain Res. 2019;12:2563-2576.
    1. Mathew S, Chamberlain C, Alvarez KS, Alvarez CA, Shah M. Impact of a pharmacy-led pain management team on adults in an academic medical center. Hosp Pharm. 2016;51(8):639-645.
    1. Vogler CN, Sattovia S, Salazar LY, Leung TI, Botchway A. Assessing outcomes of educational videos in group visits for patients with chronic pain at an academic primary care clinic. Postgrad Med. 2017;129(5):524-530.
    1. McDermott M, Smith BH, Elliott AM, Bond CM, Hannaford PC, Chambers WA. The use of medication for chronic pain in primary care, and the potential for intervention by a practice-based pharmacist. Fam Pract. 2006;23(1):46-52.
    1. Aryani FMY, Lee SWH, Chua SS, Kok LC, Efendie B, Paraidathathu T. Chronic care model in primary care: can it improve health-related quality of life? Integr Pharm Res Pract. 2016;5:11-17.
    1. Lee SWH, Mak VSL, Tang YW. Pharmacist services in nursing homes: a systematic review and meta-analysis. Br J Clin Pharmacol. 2019;85(12):2668-2688.
    1. Hadi MA, Alldred DP, Closs SJ, Briggs M. Effectiveness of pharmacist-led medication reviews in improving patient outcomes in chronic pain: a systematic review protocol. Can Pharm J/Revue des Pharmaciens du Canada. 2012;145(6):264-266.
    1. Chua SS, Kok LC, Yusof FAM, et al. Pharmaceutical care issues identified by pharmacists in patients with diabetes, hypertension or hyperlipidaemia in primary care settings. BMC Health Serv Res. 2012;12(1):388.
    1. Kua C-H, Yeo CY, Tan PC, et al. Association of deprescribing with reduction in mortality and hospitalization: a pragmatic stepped-wedge cluster-randomized controlled trial. J Am Med Dir Assoc. 2020;22(1):82-89.
    1. Lee S, Chong C, Chong D. Identifying and addressing drug-related problems in nursing homes: an unmet need in Malaysia? Int J Clin Pract. 2016;70(6):512.
    1. Read RW, Krska J. Potential roles of the pharmacist in chronic pain management: a multidisciplinary perspective in primary care. Int J Pharm Pract. 1998;6(4):223-228.
    1. Estévez-López F. Assessment of physical function: considerations in chronic pain populations. Pain. 2017;158(7):1397.
    1. Karayannis VN, Sturgeon JA, Chih-Kao M, Cooley C, Mackey SC. Pain interference and physical function demonstrate poor longitudinal association in people living with pain: a PROMIS investigation. Pain. 2017;158(6):1063-1068.
    1. Guildford BJ, Jacobs CM, Daly-Eichenhardt A, Scott W, McCracken LM. Assessing physical functioning on pain management programmes: the unique contribution of directly assessed physical performance measures and their relationship to self-reports. Br J Pain. 2017;11(1):46-57.
    1. NICE. Chronic pain in over 16s: assessment and management. NICE draft guideline, August, 2020.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する